BREAST CONSERVING THERAPY IN STAGE T1 ＆ T2 BREAST CANCER PATIENTS

• Published in: Chinese journal of cancer research Vol. 17; no. 2; pp. 137 - 139
• Main Author: 范江 吴炅 陆劲松 王磊 侯意枫 王杰 狄根红 沈坤炜 韩企夏 刘邦令 沈镇宙 邵志敏
• Format: Journal Article
• Language: English
• Published: Department of Breast Surgery, Department of Oncology, Cancer Hospital, Shanghai Medical College, Fudan University, Shanghai 200032 01.06.2005
• Subjects: 乳腺癌; 保守治疗; 化学治疗; 放射治疗; Breast carcinoma; Breast conserving therapy; Survival rate
• ISSN: 1000-9604; 1993-0631
• DOI: 10.1007/s11670-005-0059-5

Objective: To investigate the effect of breast-conservation therapy in early stage breast cancer. Methods: A total of 234 early stage breast carcinoma patients received breast conserving treatment in our hospital. After the operation, they underwent adjuvant chemotherapy and radiotherapy. All of these patients desired to preserve their breasts. Results: After median follow-up of 29.46 months (range from 3 to 100 months), 3 cases had local relapse and 8 cases had distant metastasis. The overall survival rate of 5 year was 96.7%, and the disease free survival rate of 5 year was 87.85%. Conclusion: For early stage breast carcinoma patients, classic quadrantectomy, axillary dissection and post-operative adjuvant chemotherapy and radiotherapy lead to excellent local control and good survival.